Loss of TET2 function can also occur via mutations in IDH1, IDH2 and WT1 (115, 116), that explain the mutual exclusivity between IDH1/2-TET2-WT1 mutations in AML (116). This evidence concerns the gene IDH1 and acute myeloid leukemia.